Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Corcept Therapeutics Incorporated company logo
Corcept Therapeutics Incorporated logo

Corcept Therapeutics Incorporated (CORT)

Profile

Company profile for Corcept Therapeutics Incorporated (CORT)
MetricValue
Full NameCorcept Therapeutics Incorporated
TickerNASDAQ: CORT
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websitecorcept.com
Employees500

Key Metrics

Corcept Therapeutics Incorporated Key Details
MetricDateValue
Price$34.73
Price, 1D Change-1.86%
Market Cap$4B
-
PE Ratio39.68
Beta1.28
Revenue$675M
Revenue, 1Y Change+39.94%
EPS$1.23
EPS, 1Y Change+30.42%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Corcept Therapeutics Incorporated chart

Events

Corcept Therapeutics Incorporated Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

CORT Estimates
MetricDateValue
EPS$1.23
EPS Estimate$0.87
EPS Est. Change-29.40%
Revenue$675.04M
Revenue Estimate$805.38M
Revenue Est. Change+19.31%
Current Price$34.73
Price Target-$95.00
Price Tgt. Change-+173.54%

🔒 Log In To Unlock Full Data

EPS

CORT EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$0.92$0.94+2.62%
$1.41$1.23-12.47%
$0.87N/A-29.40%
$0.69N/A-43.80%
CORT EPS reported versus estimate values chart

Revenue

CORT revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$476.28M$482.38M+1.28%
$693.23M$675.04M-2.62%
$805.38MN/A+19.31%
$1.05BN/A+55.38%
CORT revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

CORT Performance
MetricDateValue
Price, 1Y-36.20%
Price, 3Y+54.77%
Market Cap, 1Y-36.16%
Market Cap, 3Y+50.97%
Revenue, 1Y+39.94%
Revenue, 3Y+84.45%
EPS, 1Y+30.42%
EPS, 3Y+37.85%

🔒 Log In To Unlock Full Data

Technical Indicators

CORT Technical Indicators
MetricDateValue
Current Price$34.73
SMA 200$72.31
SMA 200 vs Price+108.21%
SMA 50$69.60
SMA 50 vs Price+100.40%
Beta1.28
ATR$3.77
14-Day RSI21.93
10-Day Volatility59.13%
1-Year Volatility133.35%

Dividends

CORT Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
Dividends Paid$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

CORT Income & Profitability
MetricDateValue
Revenue$675.04M
EPS$1.23
Gross Profit$664.16M
Gross Margin98.39%
Operating Profit$136.95M
Operating Margin20.29%
Net Income$139.73M
Net Margin20.70%
EBITDA$138.29M

🔒 Log In To Unlock Full Data

Financial Health

CORT Financial Health
MetricDateValue
Debt To Equity0.01
Current Ratio3.35
Quick Ratio3.26
-
F-Score5
Altman Z-Score16.34

Valuations

CORT Valuations
MetricDateValue
PE Ratio39.68
PS Ratio4.93
PB Ratio5.78
EV/EBITDA48.01
Enterprise ValueN/A-

Balance Sheet

CORT Balance Sheet
MetricDateValue
Book Value$679.59M
Cash & Equivalents$383.33M
Total Assets$840.55M
Current Assets$471.60M
Total Liabilities$160.96M
Current Liabilities$140.77M
Total Debt$6.94M
Short Term Debt$829.00K
Accounts Payable$15.38M

Expenses

CORT Expenses
MetricDateValue
Total Expenses$538.09M
Operating Expenses$527.21M
Cost Of Goods Sold$10.88M
SG&A$0.00
D&A$1.34M
Interest Expense$0.00
Income Tax$20.28M

Cash Flow

CORT Cash Flow
MetricDateValue
CFO$198.07M
CFI-$177.60M
CFF-$28.35M
Capex$2.17M
Free Cash Flow$195.90M

Recent analyst updates

CORT Recent analyst updates
MetricDateValue
HC Wainwright & Co.→
Canaccord Genuity→
UBS
HC Wainwright & Co.→
Wolfe Research
HC Wainwright & Co.→
HC Wainwright & Co.→
Canaccord Genuity→
Canaccord Genuity→
Piper Sandler→

Analyst sentiment

Sentiment over the past month
CORT analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
CORT institutional ownership distribution chart

Screeners with CORT

FAQ

  • What is the ticker symbol for Corcept Therapeutics Incorporated?

    The ticker symbol for Corcept Therapeutics Incorporated is NASDAQ:CORT

  • Does Corcept Therapeutics Incorporated pay dividends?

    No, Corcept Therapeutics Incorporated does not pay dividends

  • What sector is Corcept Therapeutics Incorporated in?

    Corcept Therapeutics Incorporated is in the Healthcare sector

  • What industry is Corcept Therapeutics Incorporated in?

    Corcept Therapeutics Incorporated is in the Biotechnology industry

  • What country is Corcept Therapeutics Incorporated based in?

    Corcept Therapeutics Incorporated is headquartered in United States

  • When did Corcept Therapeutics Incorporated go public?

    Corcept Therapeutics Incorporated initial public offering (IPO) was on April 14, 2004

  • Is Corcept Therapeutics Incorporated in the S&P 500?

    No, Corcept Therapeutics Incorporated is not included in the S&P 500 index

  • Is Corcept Therapeutics Incorporated in the NASDAQ 100?

    No, Corcept Therapeutics Incorporated is not included in the NASDAQ 100 index

  • Is Corcept Therapeutics Incorporated in the Dow Jones?

    No, Corcept Therapeutics Incorporated is not included in the Dow Jones index

  • When was Corcept Therapeutics Incorporated last earnings report?

    Corcept Therapeutics Incorporated's most recent earnings report was on November 4, 2025

  • When does Corcept Therapeutics Incorporated report earnings?

    The next expected earnings date for Corcept Therapeutics Incorporated is February 25, 2026

Data Sources & References

  1. CORT Official Website www.corcept.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1088856/000162828025048841/0001628280-25-048841-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1088856/000162828025008167/0001628280-25-008167-index.htm
  4. CORT Profile on Yahoo Finance finance.yahoo.com/quote/CORT
  5. CORT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cort